ETAR Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of ETAR monoclonal antibodies for advanced research in pharmacology and cell signaling. ETAR monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The endothelin A receptor (ETAR) plays a crucial role in mediating the effects of endothelin-1, a potent vasoconstrictor involved in regulating blood pressure and vascular tone. Dysregulation of ETAR signaling has been implicated in various cardiovascular diseases, making ETAR a significant target for therapeutic intervention. Understanding the function and regulation of ETAR is essential for developing strategies to combat conditions such as hypertension and heart failure. ETAR monoclonal antibodies enable researchers to investigate cellular pathways and molecular mechanisms involved in cardiovascular health. Exploring ETAR expression patterns helps identify potential therapeutic targets for cardiovascular disease treatment. Investigating ETAR signaling pathways provides insights into blood pressure regulation and vascular function. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing our understanding of cardiovascular biology and developing new therapeutic strategies.